{
    "nctId": "NCT02604069",
    "briefTitle": "Detection of Flap Ischemia Using Interstitial Glucose Monitor",
    "officialTitle": "Postoperative Monitoring of Tissue Perfusion in Microvascular Free Flaps Using Continuous Interstitial Glucose Monitoring Device: A Pilot Study",
    "overallStatus": "UNKNOWN",
    "conditions": "Free Tissue Flaps",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Temporal correlation between interstitial glucose measurements and flap ischemia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who are undergoing unilateral or bilateral breast reconstruction with free flap including DIEP flaps at Hamilton Health Sciences, starting from the date of ethics approval.\n\nExclusion Criteria:\n\n* Patients with diabetes (on oral antiglycemic medications or insulin-dependent)\n* Patients who are on immunosuppressive medication\n* Patients undergoing breast reconstruction involving expanders or implants\n* Patients with active infections",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}